Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1009

1.

A consensus-based transparency checklist.

Aczel B, Szaszi B, Sarafoglou A, Kekecs Z, Kucharský Š, Benjamin D, Chambers CD, Fisher A, Gelman A, Gernsbacher MA, Ioannidis JP, Johnson E, Jonas K, Kousta S, Lilienfeld SO, Lindsay DS, Morey CC, Monafò M, Newell BR, Pashler H, Shanks DR, Simons DJ, Wicherts JM, Albarracin D, Anderson ND, Antonakis J, Arkes HR, Back MD, Banks GC, Beevers C, Bennett AA, Bleidorn W, Boyer TW, Cacciari C, Carter AS, Cesario J, Clifton C, Conroy RM, Cortese M, Cosci F, Cowan N, Crawford J, Crone EA, Curtin J, Engle R, Farrell S, Fearon P, Fichman M, Frankenhuis W, Freund AM, Gaskell MG, Giner-Sorolla R, Green DP, Greene RL, Harlow LL, de la Guardia FH, Isaacowitz D, Kolodner J, Lieberman D, Logan GD, Mendes WB, Moersdorf L, Nyhan B, Pollack J, Sullivan C, Vazire S, Wagenmakers EJ.

Nat Hum Behav. 2019 Dec 2. doi: 10.1038/s41562-019-0772-6. [Epub ahead of print] No abstract available.

PMID:
31792401
2.

Use and reporting of Bland-Altman analyses in studies of self-reported versus measured weight and height.

Flegal KM, Graubard B, Ioannidis JPA.

Int J Obes (Lond). 2019 Dec 2. doi: 10.1038/s41366-019-0499-5. [Epub ahead of print]

PMID:
31792334
3.

True and false positive rates for different criteria of evaluating statistical evidence from clinical trials.

van Ravenzwaaij D, Ioannidis JPA.

BMC Med Res Methodol. 2019 Nov 27;19(1):218. doi: 10.1186/s12874-019-0865-y.

4.

Most recommended medical interventions reach P<0.005 for their primary outcomes in meta-analyses.

Koletsi D, Solmi M, Pandis N, Fleming PS, Correll CU, Ioannidis JPA.

Int J Epidemiol. 2019 Nov 25. pii: dyz241. doi: 10.1093/ije/dyz241. [Epub ahead of print]

PMID:
31764988
5.

The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement.

Kent DM, Paulus JK, van Klaveren D, D'Agostino R, Goodman S, Hayward R, Ioannidis JPA, Patrick-Lake B, Morton S, Pencina M, Raman G, Ross JS, Selker HP, Varadhan R, Vickers A, Wong JB, Steyerberg EW.

Ann Intern Med. 2019 Nov 12. doi: 10.7326/M18-3667. [Epub ahead of print]

PMID:
31711134
6.

The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration.

Kent DM, van Klaveren D, Paulus JK, D'Agostino R, Goodman S, Hayward R, Ioannidis JPA, Patrick-Lake B, Morton S, Pencina M, Raman G, Ross JS, Selker HP, Varadhan R, Vickers A, Wong JB, Steyerberg EW.

Ann Intern Med. 2019 Nov 12. doi: 10.7326/M18-3668. [Epub ahead of print]

PMID:
31711094
7.

Prevalence and significance of race and ethnicity subgroup analyses in Cochrane intervention reviews.

Liu P, Ross JS, Ioannidis JP, Dhruva SS, Vasiliou V, Wallach JD.

Clin Trials. 2019 Nov 10:1740774519887148. doi: 10.1177/1740774519887148. [Epub ahead of print] No abstract available.

PMID:
31709809
8.

Non-randomized studies using causal-modelling may give different answers than RCTs: a meta-epidemiological study.

Ewald H, Ioannidis JP, Ladanie A, Cord KM, Bucher HC, Hemkens LG.

J Clin Epidemiol. 2019 Nov 5. pii: S0895-4356(19)30263-X. doi: 10.1016/j.jclinepi.2019.10.012. [Epub ahead of print]

PMID:
31704350
9.

Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study.

Liu P, Ioannidis JPA, Ross JS, Dhruva SS, Luxkaranayagam AT, Vasiliou V, Wallach JD.

BMC Med. 2019 Oct 21;17(1):188. doi: 10.1186/s12916-019-1420-8.

10.

Neglecting Major Health Problems and Broadcasting Minor, Uncertain Issues in Lifestyle Science.

Ioannidis JPA.

JAMA. 2019 Oct 18:1-2. doi: 10.1001/jama.2019.17576. [Epub ahead of print] No abstract available.

PMID:
31626274
11.

Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug development.

Mastellos DC, Blom AM, Connolly ES, Daha MR, Geisbrecht BV, Ghebrehiwet B, Gros P, Hajishengallis G, Holers VM, Huber-Lang M, Kinoshita T, Mollnes TE, Montgomery RA, Morgan BP, Nilsson B, Pio R, Ricklin D, Risitano AM, Taylor RP, Mantovani A, Ioannidis JPA, Lambris JD.

Nat Immunol. 2019 Nov;20(11):1556. doi: 10.1038/s41590-019-0531-x.

PMID:
31605100
12.

The Accuracy of the Patient Health Questionnaire-9 Algorithm for Screening to Detect Major Depression: An Individual Participant Data Meta-Analysis.

He C, Levis B, Riehm KE, Saadat N, Levis AW, Azar M, Rice DB, Krishnan A, Wu Y, Sun Y, Imran M, Boruff J, Cuijpers P, Gilbody S, Ioannidis JPA, Kloda LA, McMillan D, Patten SB, Shrier I, Ziegelstein RC, Akena DH, Arroll B, Ayalon L, Baradaran HR, Baron M, Beraldi A, Bombardier CH, Butterworth P, Carter G, Chagas MHN, Chan JCN, Cholera R, Clover K, Conwell Y, de Man-van Ginkel JM, Fann JR, Fischer FH, Fung D, Gelaye B, Goodyear-Smith F, Greeno CG, Hall BJ, Harrison PA, Härter M, Hegerl U, Hides L, Hobfoll SE, Hudson M, Hyphantis TN, Inagaki M, Ismail K, Jetté N, Khamseh ME, Kiely KM, Kwan Y, Lamers F, Liu SI, Lotrakul M, Loureiro SR, Löwe B, Marsh L, McGuire A, Mohd-Sidik S, Munhoz TN, Muramatsu K, Osório FL, Patel V, Pence BW, Persoons P, Picardi A, Reuter K, Rooney AG, da Silva Dos Santos IS, Shaaban J, Sidebottom A, Simning A, Stafford L, Sung S, Tan PLL, Turner A, van Weert HCPM, White J, Whooley MA, Winkley K, Yamada M, Thombs BD, Benedetti A.

Psychother Psychosom. 2019 Oct 8:1-13. doi: 10.1159/000502294. [Epub ahead of print]

PMID:
31593971
13.

Evidence Relating Health Care Provider Burnout and Quality of Care: A Systematic Review and Meta-analysis.

Tawfik DS, Scheid A, Profit J, Shanafelt T, Trockel M, Adair KC, Sexton JB, Ioannidis JPA.

Ann Intern Med. 2019 Oct 8. doi: 10.7326/M19-1152. [Epub ahead of print]

PMID:
31590181
14.

Excess Significance Bias in Repetitive Transcranial Magnetic Stimulation Literature for Neuropsychiatric Disorders.

Amad A, Jardri R, Rousseau C, Larochelle Y, Ioannidis JPA, Naudet F.

Psychother Psychosom. 2019;88(6):363-370. doi: 10.1159/000502805. Epub 2019 Oct 7.

PMID:
31590171
15.

Comparison of major depression diagnostic classification probability using the SCID, CIDI, and MINI diagnostic interviews among women in pregnancy or postpartum: An individual participant data meta-analysis.

Levis B, McMillan D, Sun Y, He C, Rice DB, Krishnan A, Wu Y, Azar M, Sanchez TA, Chiovitti MJ, Bhandari PM, Neupane D, Saadat N, Riehm KE, Imran M, Boruff JT, Cuijpers P, Gilbody S, Ioannidis JPA, Kloda LA, Patten SB, Shrier I, Ziegelstein RC, Comeau L, Mitchell ND, Tonelli M, Vigod SN, Aceti F, Alvarado R, Alvarado-Esquivel C, Bakare MO, Barnes J, Beck CT, Bindt C, Boyce PM, Bunevicius A, Couto TCE, Chaudron LH, Correa H, de Figueiredo FP, Eapen V, Fernandes M, Figueiredo B, Fisher JRW, Garcia-Esteve L, Giardinelli L, Helle N, Howard LM, Khalifa DS, Kohlhoff J, Kusminskas L, Kozinszky Z, Lelli L, Leonardou AA, Lewis BA, Maes M, Meuti V, Nakić Radoš S, Navarro García P, Nishi D, Okitundu Luwa E-Andjafono D, Robertson-Blackmore E, Rochat TJ, Rowe HJ, Siu BWM, Skalkidou A, Stein A, Stewart RC, Su KP, Sundström-Poromaa I, Tadinac M, Tandon SD, Tendais I, Thiagayson P, Töreki A, Torres-Giménez A, Tran TD, Trevillion K, Turner K, Vega-Dienstmaier JM, Wynter K, Yonkers KA, Benedetti A, Thombs BD.

Int J Methods Psychiatr Res. 2019 Sep 30:e1803. doi: 10.1002/mpr.1803. [Epub ahead of print]

PMID:
31568624
16.

'Stealth' corporate innovation: an emerging threat for therapeutic drug development.

Mastellos DC, Blom AM, Connolly ES, Daha MR, Geisbrecht BV, Ghebrehiwet B, Gros P, Hajishengallis G, Holers VM, Huber-Lang M, Kinoshita T, Mollnes TE, Montgomery RA, Morgan BP, Nilsson B, Pio R, Ricklin D, Risitano AM, Taylor RP, Mantovani A, Ioannidis JPA, Lambris JD.

Nat Immunol. 2019 Nov;20(11):1409-1413. doi: 10.1038/s41590-019-0503-1. No abstract available. Erratum in: Nat Immunol. 2019 Oct 11;:.

PMID:
31562490
17.

Mapping the universe of registered reports.

Hardwicke TE, Ioannidis JPA.

Nat Hum Behav. 2018 Nov;2(11):793-796. doi: 10.1038/s41562-018-0444-y. No abstract available.

PMID:
31558810
18.

Ninth international congress on peer review and scientific publication: call for research.

Ioannidis JPA, Berkwits M, Flanagin A, Godlee F, Bloom T.

BMJ. 2019 Sep 16;366:l5475. doi: 10.1136/bmj.l5475. No abstract available.

PMID:
31527134
19.

Vibration of effects from diverse inclusion/exclusion criteria and analytical choices: 9216 different ways to perform an indirect comparison meta-analysis.

Palpacuer C, Hammas K, Duprez R, Laviolle B, Ioannidis JPA, Naudet F.

BMC Med. 2019 Sep 16;17(1):174. doi: 10.1186/s12916-019-1409-3.

20.

The Ninth International Congress on Peer Review and Scientific Publication: A Call for Research.

Ioannidis JPA, Berkwits M, Flanagin A, Godlee F, Bloom T.

JAMA. 2019 Sep 16. doi: 10.1001/jama.2019.15516. [Epub ahead of print] No abstract available.

PMID:
31524942
21.

US Food and Drug Administration Approvals of Drugs and Devices Based on Nonrandomized Clinical Trials: A Systematic Review and Meta-analysis.

Razavi M, Glasziou P, Klocksieben FA, Ioannidis JPA, Chalmers I, Djulbegovic B.

JAMA Netw Open. 2019 Sep 4;2(9):e1911111. doi: 10.1001/jamanetworkopen.2019.11111.

22.

Toward a paradigm shift in treatment and research of mental disorders.

Leichsenring F, Steinert C, Ioannidis JPA.

Psychol Med. 2019 Oct;49(13):2111-2117. doi: 10.1017/S0033291719002265. Epub 2019 Sep 2. No abstract available.

PMID:
31474241
23.

Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials.

Lanini S, Ioannidis JPA, Vairo F, Pletschette M, Portella G, Di Bari V, Mammone A, Pisapia R, Merler S, Nguhuni B, Langer M, Di Caro A, Edwards SJL, Petrosillo N, Zumla A, Ippolito G.

Lancet Infect Dis. 2019 Dec;19(12):e444-e451. doi: 10.1016/S1473-3099(19)30284-1. Epub 2019 Aug 23. Review.

PMID:
31451421
24.

Air pollution as cause of mental disease: Appraisal of the evidence.

Ioannidis JPA.

PLoS Biol. 2019 Aug 20;17(8):e3000370. doi: 10.1371/journal.pbio.3000370. eCollection 2019 Aug.

25.

Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis - ERRATUM.

Wu Y, Levis B, Riehm KE, Saadat N, Levis AW, Azar M, Rice DB, Boruff J, Cuijpers P, Gilbody S, Ioannidis JPA, Kloda LA, McMillan D, Patten SB, Shrier I, Ziegelstein RC, Akena DH, Arroll B, Ayalon L, Baradaran HR, Baron M, Bombardier CH, Butterworth P, Carter G, Chagas MH, Chan JCN, Cholera R, Conwell Y, de Manvan Ginkel JM, Fann JR, Fischer FH, Fung D, Gelaye B, Goodyear-Smith F, Greeno CG, Hall BJ, Harrison PA, Härter M, Hegerl U, Hides L, Hobfoll SE, Hudson M, Hyphantis T, Inagaki M, Jetté N, Khamseh ME, Kiely KM, Kwan Y, Lamers F, Liu SI, Lotrakul M, Loureiro SR, Löwe B, McGuire A, Mohd-Sidik S, Munhoz TN, Muramatsu K, Osório FL, Patel V, Pence BW, Persoons P, Picardi A, Reuter K, Rooney AG, Santos IS, Shaaban J, Sidebottom A, Simning A, Stafford L, Sung S, Tan PLL, Turner A, van Weert HC, White J, Whooley MA, Winkley K, Yamada M, Benedetti A, Thombs BD.

Psychol Med. 2019 Aug 19:1. doi: 10.1017/S0033291719002137. [Epub ahead of print] No abstract available.

PMID:
31423953
26.

An empirical assessment of research practices across 163 clinical trials of tumor-bearing companion dogs.

Tan YJ, Crowley RJ, Ioannidis JPA.

Sci Rep. 2019 Aug 15;9(1):11877. doi: 10.1038/s41598-019-48425-5.

27.

Publishing research with P-values: Prescribe more stringent statistical significance or proscribe statistical significance?

Ioannidis JPA.

Eur Heart J. 2019 Aug 14;40(31):2553-2554. doi: 10.1093/eurheartj/ehz555. No abstract available.

PMID:
31411718
28.

Options for publishing research without any P-values.

Ioannidis JPA.

Eur Heart J. 2019 Aug 14;40(31):2555-2556. doi: 10.1093/eurheartj/ehz556. No abstract available.

PMID:
31411717
29.

A standardized citation metrics author database annotated for scientific field.

Ioannidis JPA, Baas J, Klavans R, Boyack KW.

PLoS Biol. 2019 Aug 12;17(8):e3000384. doi: 10.1371/journal.pbio.3000384. eCollection 2019 Aug.

30.

Petitions in scientific argumentation: Dissecting the request to retire statistical significance.

Hardwicke TE, Ioannidis JPA.

Eur J Clin Invest. 2019 Oct;49(10):e13162. doi: 10.1111/eci.13162. Epub 2019 Sep 16. No abstract available.

PMID:
31380567
31.

Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis.

Wu Y, Levis B, Riehm KE, Saadat N, Levis AW, Azar M, Rice DB, Boruff J, Cuijpers P, Gilbody S, Ioannidis JPA, Kloda LA, McMillan D, Patten SB, Shrier I, Ziegelstein RC, Akena DH, Arroll B, Ayalon L, Baradaran HR, Baron M, Bombardier CH, Butterworth P, Carter G, Chagas MH, Chan JCN, Cholera R, Conwell Y, de Man-van Ginkel JM, Fann JR, Fischer FH, Fung D, Gelaye B, Goodyear-Smith F, Greeno CG, Hall BJ, Harrison PA, Härter M, Hegerl U, Hides L, Hobfoll SE, Hudson M, Hyphantis T, Inagaki MD, Jetté N, Khamseh ME, Kiely KM, Kwan Y, Lamers F, Liu SI, Lotrakul M, Loureiro SR, Löwe B, McGuire A, Mohd-Sidik S, Munhoz TN, Muramatsu K, Osório FL, Patel V, Pence BW, Persoons P, Picardi A, Reuter K, Rooney AG, Santos IS, Shaaban J, Sidebottom A, Simning A, Stafford MD, Sung S, Tan PLL, Turner A, van Weert HC, White J, Whooley MA, Winkley K, Yamada M, Benedetti A, Thombs BD.

Psychol Med. 2019 Jul 12:1-13. doi: 10.1017/S0033291719001314. [Epub ahead of print]

PMID:
31298180
32.

A systematic review of the genetic mechanisms of dolutegravir resistance.

Rhee SY, Grant PM, Tzou PL, Barrow G, Harrigan PR, Ioannidis JPA, Shafer RW.

J Antimicrob Chemother. 2019 Nov 1;74(11):3135-3149. doi: 10.1093/jac/dkz256.

33.

A limited number of medicines pragmatic trials had potential for waived informed consent following the 2016 CIOMS ethical guidelines.

Dal-Ré R, Avendaño-Solà C, de Boer A, James SK, Rosendaal FR, Stephens R, Ioannidis JPA.

J Clin Epidemiol. 2019 Oct;114:60-71. doi: 10.1016/j.jclinepi.2019.06.007. Epub 2019 Jun 15.

PMID:
31212001
34.

A user's guide to inflated and manipulated impact factors.

Ioannidis JPA, Thombs BD.

Eur J Clin Invest. 2019 Sep;49(9):e13151. doi: 10.1111/eci.13151. Epub 2019 Jul 1. No abstract available.

PMID:
31206647
35.

Solutions to Reduce Unnecessary Imaging-Reply.

Oren O, Kebebew E, Ioannidis JPA.

JAMA. 2019 Jun 11;321(22):2243. doi: 10.1001/jama.2019.4021. No abstract available.

PMID:
31184737
36.

Interventions to improve cardiopulmonary resuscitation: a review of meta-analyses and future agenda.

Chalkias A, Ioannidis JPA.

Crit Care. 2019 Jun 7;23(1):210. doi: 10.1186/s13054-019-2495-5. No abstract available.

37.

Risk and protective factors for anxiety and obsessive-compulsive disorders: an umbrella review of systematic reviews and meta-analyses.

Fullana MA, Tortella-Feliu M, Fernández de la Cruz L, Chamorro J, Pérez-Vigil A, Ioannidis JPA, Solanes A, Guardiola M, Almodóvar C, Miranda-Olivos R, Ramella-Cravaro V, Vilar A, Reichenberg A, Mataix-Cols D, Vieta E, Fusar-Poli P, Fatjó-Vilas M, Radua J.

Psychol Med. 2019 Jun 7:1-16. doi: 10.1017/S0033291719001247. [Epub ahead of print]

PMID:
31172897
38.

Family History-Wide Association Study to Identify Clinical and Environmental Risk Factors for Common Chronic Diseases.

Rasooly D, Ioannidis JPA, Khoury MJ, Patel CJ.

Am J Epidemiol. 2019 Aug 1;188(8):1563-1568. doi: 10.1093/aje/kwz125.

39.

Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies.

Ladanie A, Speich B, Briel M, Sclafani F, Bucher HC, Agarwal A, Ioannidis JPA, Pereira TV, Kasenda B, Hemkens LG.

J Clin Epidemiol. 2019 Oct;114:49-59. doi: 10.1016/j.jclinepi.2019.05.033. Epub 2019 May 31.

PMID:
31158450
40.

Validation protocols for blood pressure measuring devices: the impact of the European Society of Hypertension International Protocol and the development of a Universal Standard.

O'Brien E, Stergiou G, Palatini P, Asmar R, Ioannidis JP, Kollias A, Lacy P, McManus RJ, Myers MG, Shennan A, Wang J, Parati G; European Society of Hypertension Working Group on Blood Pressure Monitoring.

Blood Press Monit. 2019 Aug;24(4):163-166. doi: 10.1097/MBP.0000000000000391.

PMID:
31116156
41.

Lost Evidence From Registered Large Long-Unpublished Randomized Controlled Trials: A Survey.

Tatsioni A, Karassa FB, Goodman SN, Zarin DA, Fanelli D, Ioannidis JPA.

Ann Intern Med. 2019 May 7. doi: 10.7326/M19-0440. [Epub ahead of print] No abstract available.

PMID:
31060046
42.

Lethal news: The dexterous infiltration of news media by the tobacco industry agenda.

Ioannidis JPA.

Eur J Clin Invest. 2019 Jul;49(7):e13125. doi: 10.1111/eci.13125. Epub 2019 May 18. No abstract available.

PMID:
31058313
43.

Consent insufficient for data release-Response.

Amann RI, Baichoo S, Blencowe BJ, Bork P, Borodovsky M, Brooksbank C, Chain PSG, Colwell RR, Daffonchio DG, Danchin A, de Lorenzo V, Dorrestein PC, Finn RD, Fraser CM, Gilbert JA, Hallam SJ, Hugenholtz P, Ioannidis JPA, Jansson JK, Kim JF, Klenk HP, Klotz MG, Knight R, Konstantinidis KT, Kyrpides NC, Mason CE, McHardy AC, Meyer F, Ouzounis CA, Patrinos AAN, Podar M, Pollard KS, Ravel J, Muñoz AR, Roberts RJ, Rosselló-Móra R, Sansone SA, Schloss PD, Schriml LM, Setubal JC, Sorek R, Stevens RL, Tiedje JM, Turjanski A, Tyson GW, Ussery DW, Weinstock GM, White O, Whitman WB, Xenarios I.

Science. 2019 May 3;364(6439):446. doi: 10.1126/science.aax7509. No abstract available.

PMID:
31048484
44.

Reproducible pharmacokinetics.

Ioannidis JPA.

J Pharmacokinet Pharmacodyn. 2019 Apr;46(2):111-116. doi: 10.1007/s10928-019-09621-y. Epub 2019 Apr 19. Review.

PMID:
31004315
45.

Meta-analyses identify differentially expressed micrornas in Parkinson's disease.

Schulz J, Takousis P, Wohlers I, Itua IOG, Dobricic V, Rücker G, Binder H, Middleton L, Ioannidis JPA, Perneczky R, Bertram L, Lill CM.

Ann Neurol. 2019 Jun;85(6):835-851. doi: 10.1002/ana.25490.

PMID:
30990912
46.

The Importance of Predefined Rules and Prespecified Statistical Analyses: Do Not Abandon Significance.

Ioannidis JPA.

JAMA. 2019 Jun 4;321(21):2067-2068. doi: 10.1001/jama.2019.4582. No abstract available.

PMID:
30946431
47.

Therapy and prevention for mental health: What if mental diseases are mostly not brain disorders?

Ioannidis JPA.

Behav Brain Sci. 2019 Jan;42:e13. doi: 10.1017/S0140525X1800105X.

PMID:
30940221
48.

How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation.

Ioannidis JPA, Kim BYS, Trounson A.

Nat Biomed Eng. 2018 Nov;2(11):797-809. doi: 10.1038/s41551-018-0314-y. Epub 2018 Nov 8.

49.

Bayes factors for superiority, non-inferiority, and equivalence designs.

van Ravenzwaaij D, Monden R, Tendeiro JN, Ioannidis JPA.

BMC Med Res Methodol. 2019 Mar 29;19(1):71. doi: 10.1186/s12874-019-0699-7.

50.

Retiring statistical significance would give bias a free pass.

Ioannidis JPA.

Nature. 2019 Mar;567(7749):461. doi: 10.1038/d41586-019-00969-2. No abstract available.

PMID:
30903096

Supplemental Content

Loading ...
Support Center